1. Home
  2. IQV vs WTW Comparison

IQV vs WTW Comparison

Compare IQV & WTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IQV
  • WTW
  • Stock Information
  • Founded
  • IQV 1982
  • WTW 1828
  • Country
  • IQV United States
  • WTW United Kingdom
  • Employees
  • IQV N/A
  • WTW N/A
  • Industry
  • IQV Biotechnology: Commercial Physical & Biological Resarch
  • WTW Specialty Insurers
  • Sector
  • IQV Health Care
  • WTW Finance
  • Exchange
  • IQV Nasdaq
  • WTW Nasdaq
  • Market Cap
  • IQV 31.0B
  • WTW 31.8B
  • IPO Year
  • IQV 2013
  • WTW N/A
  • Fundamental
  • Price
  • IQV $179.92
  • WTW $327.85
  • Analyst Decision
  • IQV Strong Buy
  • WTW Strong Buy
  • Analyst Count
  • IQV 19
  • WTW 9
  • Target Price
  • IQV $229.37
  • WTW $360.56
  • AVG Volume (30 Days)
  • IQV 2.4M
  • WTW 754.8K
  • Earning Date
  • IQV 07-22-2025
  • WTW 07-31-2025
  • Dividend Yield
  • IQV N/A
  • WTW 1.12%
  • EPS Growth
  • IQV N/A
  • WTW N/A
  • EPS
  • IQV 6.92
  • WTW 1.33
  • Revenue
  • IQV $15,700,000,000.00
  • WTW $9,808,000,000.00
  • Revenue This Year
  • IQV $6.03
  • WTW N/A
  • Revenue Next Year
  • IQV $5.03
  • WTW $5.58
  • P/E Ratio
  • IQV $25.98
  • WTW $247.22
  • Revenue Growth
  • IQV 3.60
  • WTW 1.26
  • 52 Week Low
  • IQV $134.65
  • WTW $273.70
  • 52 Week High
  • IQV $252.88
  • WTW $344.14
  • Technical
  • Relative Strength Index (RSI)
  • IQV 53.66
  • WTW 67.40
  • Support Level
  • IQV $176.47
  • WTW $322.40
  • Resistance Level
  • IQV $184.62
  • WTW $320.18
  • Average True Range (ATR)
  • IQV 6.73
  • WTW 6.24
  • MACD
  • IQV -1.87
  • WTW 2.04
  • Stochastic Oscillator
  • IQV 26.65
  • WTW 96.40

About IQV IQVIA Holdings Inc.

Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

About WTW Willis Towers Watson Public Limited Company

Willis Towers Watson PLC is an advisory, broking, and solutions company that provides data-driven, insight-led solutions in the areas of people, risk, and capital. The company's segments include Health, Wealth & Career (HWC) and Risk & Broking (R&B). The HWC segment provides an array of advice, broking, solutions and technology for employee benefit plans, institutional investors, compensation and career programs, and employee experience overall. It focuses on four key areas: Health, Wealth, Career and Benefits Delivery & Outsourcing. The R&B segment provides risk advice, insurance brokerage and consulting services to clients ranging from small businesses to multinational corporations. Its R&B segment includes two businesses: Corporate Risk & Broking and Insurance Consulting and Technology.

Share on Social Networks: